Does Physiological Blood Glucose Control Require an Adaptive Control Strategy?
- 1 August 1987
- journal article
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Biomedical Engineering
- Vol. BME-34 (8) , 575-582
- https://doi.org/10.1109/tbme.1987.326068
Abstract
To test the hypothesis that only an adaptive algorithm would guarantee optimal feedback control of glycemia in insulin-dependent diabetes, fasting chronically diabetic dogs at rest were subjected to short-term artificial beta cell treatment. Insulin was applied intravenously and an oral glucose load was given during the experiment. Employing the same dosing algorithm, three different control strategies were employed in a random order on different days: adaptive control (minimum variance controller, Test A), fixed command control using on-line parameter estimates (Test B), and fixed command control using off-line individually optimized dosage constants (Test C). Comparison was made to nondiabetic control animals. The glycemic profiles were entirely normal in Test A and C, but were distinctly elevated in Test B. The peripheral hyperinsulinaemia could, however, not be avoided by adaptive control. It is concluded that the restoration of physiological blood glucose control in insulin-dependent diabetes requires dosage parameters which are either continually adapted to the actual situation (adaptive control) or are optimized to meet the individual's needs. In the latter case, fixed command control may be employed. Peripheral hyperinsulinaemia cannot be avoided as long as insulin is administered by a posthepatic route.Keywords
This publication has 33 references indexed in Scilit:
- Continuous Peritoneal Insulin Infusion with Portable Pumps: Factors Affecting the Operating Life of the Chronic CatheterDiabetes Care, 1985
- Fortschritte in der Diabeteseinstellung durch den Einsatz eines patientenindividuell adaptierten Insulin-Glucose-ModellsBiomedizinische Technik/Biomedical Engineering, 1984
- Adaptive control system for blood glucose regulationTransactions of the Institute of Measurement and Control, 1983
- WEARABLE ARTIFICIAL ENDOCRINE PANCREAS WITH NEEDLE-TYPE GLUCOSE SENSORThe Lancet, 1982
- The Use of an Implantable Insulin Pump in the Treatment of Type II DiabetesNew England Journal of Medicine, 1982
- Glucose Sensor Characteristics for Miniaturized Portable Closed-Loop Insulin Delivery: A Step Toward ImplantationDiabetes Care, 1982
- Comparison of 24-Hour Insulin Requirements in IDDM Patients during Control by an Artificial Betacell and during Conventional TherapyHormone and Metabolic Research, 1981
- Programming of Insulin Delivery with Meals During Subcutaneous Insulin InfusionDiabetes Care, 1981
- Hyperinsulinism Complicating Control of Diabetes Mellitus by an Artificial Beta-CellDiabetes Care, 1980
- Studies with an artificial endocrine pancreasArchives of internal medicine (1960), 1977